Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4501 AL 4515

Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative

Gonzalez-Latapi P, Gochanour C, Choi SH, Cho H, Caspell-Garcia C, Coffey CS, Lafontant DE, Xiao Y, Tanner CM, Venuto CS, Kieburtz K, Chahine LM, Poston KL, Galasko D, Picillo M, Siderowf A, Tropea TF, Simuni T, Marek K; Parkinson's Progression Markers Initiative.

Ann Neurol. 2026 Oct;100 Suppl 38:S36-S46. doi: 10.1002/ana.78248. Epub 2026 May 18.

Amyloid and Tau Co-pathology in Parkinson Disease and Atypical Parkinsonism

Angel Pinto MJ, García Cordero I, Dorman G, Mizraji G, Anastassiadis C, Gershanik O, Couto B.

Curr Neurol Neurosci Rep. 2026 Mar 25;26(1):21. doi: 10.1007/s11910-026-01488-0.

Exercise as a potent antidepressant intervention in Parkinson's disease: a systematic review and meta-analysis of randomised controlled trials

Sun C, Yan Y, Zhu M, Ma H, Xie H.

Front Psychol. 2026 May 14;17:1846067. doi: 10.3389/fpsyg.2026.1846067. eCollection 2026.

Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease

Tropea TF, Stevenson PA, Flitter M, Meehan D, Morris A, Lu M, Iaccarino L, Collins EC, Hodsdon ME, Irwin D, Spindler M, Deik A, Dahodwala N, Cousins KAQ, Wolk DA, Shaw L, Weintraub D, Lee EB, Chen-Plotkin A, Mintun M, Siderowf A.

Ann Neurol. 2026 Jun;99(6):1428-1437. doi: 10.1002/ana.78201. Epub 2026 Mar 18.

Association between dairy consumption and Parkinson's disease: A systematic review and meta-analysis

Yang D, Nepal G, Ojha R, Tu Z.

Public Health. 2026 Mar;252:106143. doi: 10.1016/j.puhe.2026.106143. Epub 2026 Jan 15.

Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial

Greenland JC, Dresser K, Cutting E, Donegan R, Bond S, Crisp SJ, Scott KM, Voysey ZJ, Holbrook J, Kahanawita L, Pal R, Camacho M, Peattie ARD, Spindler LRB, Hong YT, Fryer TD, Williams-Gray CH.

Lancet Neurol. 2026 Jan;25(1):39-49. doi: 10.1016/S1474-4422(25)00386-2.

Parkinson's Disease: Is It Hidden in the Gut Ecology the Ariadne's Thread Leading to Help?

Marotta F, Ahmadi AM, Kushugulova A, Catanzaro R, Rastmanesh R, Rasulova S, Haghsnenas L.

J Dig Dis. 2026 Mar 31. doi: 10.1111/1751-2980.70043. Online ahead of print.

Revisiting cirrhosis-related parkinsonism: a comprehensive review

Fernández-Garza LE, González-Torres LA, Estrada-Bellmann I, Cortez-Hernández CA, Fernández-Garza VA, Nomura-Quiroz RP, Navarrete-Rodríguez A.

Metab Brain Dis. 2026 May 23;41(1):112. doi: 10.1007/s11011-026-01875-z.

Evaluating climbing interventions for Parkinson's disease: a systematic review

Smith RA, Hellman AA.

Front Sports Act Living. 2026 Mar 13;8:1695888. doi: 10.3389/fspor.2026.1695888. eCollection 2026.

Subcutaneous Levodopa in Parkinson's Disease: A Systematic Review and Meta-Analysis

Burton M, Marsden D, Harish D, Morris P, Heneghan C, Butler A, Nunan D.

Eur J Neurol. 2026 Feb;33(2):e70506. doi: 10.1111/ene.70506.

Impact of Alcohol Intake on Parkinson's Disease Risk and Progression: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies

Hemeda S, Elmadani M, Merzah M, Odeh A, Pintér E, Balás I, Janszky J, Pintér D, Kovács N.

Mov Disord. 2026 Apr;41(4):843-855. doi: 10.1002/mds.70200. Epub 2026 Jan 24.

Artificial intelligence and multiomics integration for Parkinson's disease drug development

Lee S, Kim J, Jung HU, Kim D, Cho E, Kim YJ, Ji YR, Go Y, Song P, Oh YS, Yoon JH.

Mol Cells. 2026 May;49(5):100343. doi: 10.1016/j.mocell.2026.100343. Epub 2026 Mar 10.

Technologies used in Parkinson's disease: a meta-analysis of their effect on health-related quality of life

Fidan C.

J Neurol. 2026 Mar 12;273(3):203. doi: 10.1007/s00415-026-13749-6.

A bibliometric analysis of alpha-synuclein in Parkinson's disease from 2015 to 2024

Xiao L, Lin S, Wu Y, Liu X, Gu D, Fan J, Zhuang L.

Front Neurol. 2026 Mar 4;17:1712325. doi: 10.3389/fneur.2026.1712325. eCollection 2026.

Partnering With Participant Advisors on the Parkinson's Progression Markers Initiative

McGuire Kuhl M, Destro C, Dobkin RD, Tropea TF, Brodkin K, Flagg E, Lemon LP, Henry B, McMahon BA, Stanley CE Jr, Matthews-McGee A, Heathers LEA, Miller M, Myers H, Foroud T, Pico C, Kelliher C, Kopil CM, Dance A, Duggan B, Goldstein FS, Robinson BS, Robinson J, Acevedo M, Clark M, Hidaka C, Moran J, Lugo P, Sugihara S, Paulson RD, Alongi PT, Comerci L, Kwok K, Kramer H, Marek K; Parkinson's Progression Markers Initiative.

Ann Neurol. 2026 Oct;100 Suppl 38:S106-S117. doi: 10.1002/ana.78220. Epub 2026 Apr 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias